Delivery Order SPE2DB22D2206-SPE2DB25FDS48

Award Date 10/9/24
Potential Completion Date 10/10/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,473.21 firm-fixed-price delivery order is for the supply of Cefixime 400 mg capsules, a common antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,287.47, is for the delivery of 4560878924 Cefixime 400 mg capsules. The award is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $3,868.86 firm fixed-price contract is for the delivery of 4,565,427,745 units of the antibiotic medication Cefixime 400 mg capsules. The order does not have a set-aside designation and has a completion date of August 13, 2024. AmerisourceBergen, through its extensive supply chain network,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,026,246 units of the antibiotic drug Cefixime 400 mg capsules. The contract has a firm fixed price of $10,740.68 and a completion date of October 7, 2024. The award is not associated with any set-aside program. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,541.09, is for the delivery of 4,563,004,539 units of the anti-infective medication Cefixime 400 mg capsules. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,727.23 firm fixed-price delivery order is for the supply of Cefixime 400 mg capsules, with a completion date of July 20, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award by the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cefixime 400 mg capsules. The $1,638.30 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,159.96 Firm Fixed Price Delivery Order provides Cefixime 400 mg capsules to the DLA. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical...
This federal contract award is for the delivery of CEFIXIME 400 MG CAPSULE 50S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a ceiling value of $6,303.74 and an ultimate completion date of September 21, 2023. The contract is not designated with any set-aside...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,959,644 units of the pharmaceutical product CEFIXIME 400 MG CAPSULE 50S. The ceiling value of the contract is $1,456.77. The contract is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of June 21, 2024. This contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDS48
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,886.22 firm-fixed price delivery order is for the supply of Cefixime 400 mg capsules, a prescription antibiotic medication. This order is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of October 10, 2024 and does not utilize a socioeconomic set-aside designation.

Generated 1/8/25, 9:30 AM